Bioproduction of Isoprenoids and Other Secondary Metabolites Using

catalysts Review Bioproduction of Isoprenoids and Other Secondary Metabolites Using Methanotrophic Bacteria as an Alternative Microbial Cell Factory Option: Current Stage and Future Aspects Young Chan Jeon, Anh Duc Nguyen and Eun Yeol Lee * Department of Chemical Engineering, Kyung Hee University, Yongin-si, Gyeonggi-do 17104, Korea; [email protected] (Y.C.J.); [email protected] (A.D.N.) * Correspondence: [email protected]; Tel.: +82-31-201-3839 Received: 28 September 2019; Accepted: 21 October 2019; Published: 24 October 2019 Abstract: Methane is a promising carbon feedstock for industrial biomanufacturing because of its low price and high abundance. Recent advances in metabolic engineering and systems biology in methanotrophs have made it possible to produce a variety of value-added compounds from methane, including secondary metabolites. Isoprenoids are one of the largest family of secondary metabolites and have many useful industrial applications. In this review, we highlight the current efforts invested to methanotrophs for the production of isoprenoids and other secondary metabolites, including riboflavin and ectoine. The future outlook for improving secondary metabolites production (especially of isoprenoids) using metabolic engineering of methanotrophs is also discussed. Keywords: methane; methanotrophs; secondary metabolites; isoprenoid; metabolic engineering 1. Introduction Methane is the major component of natural gas and a huge amount of methane is available due to advances in natural and shale gas production technology [1]. Unfortunately, atmospheric methane is 20 times as potent as carbon dioxide as a greenhouse gas that needs to be mitigated. Of the total methane emissions, anthropogenic emissions (combustion of fossil fuels, livestock industry, landfills, and biomass burning) account for 63%, and natural sources (wetlands, oceans, rivers, lakes, and permafrost) account for 37%. Anthropogenic emissions have steadily increased, with an increase in methane gas production as relevant industry develops [2,3]. Currently, most methane is used to produce electricity in gas turbine boilers and is supplied to homes for heating and cooking [4]. One challenging technical issue on methane utilization is gas-to-liquid (GTL) conversion because methane gas is not easily transported [5]. Various chemical GTL conversion technologies have been developed to date, but there are some disadvantages. The chemical gas-to-liquid conversion technology consists of a methane reforming process to produce syngas, a Fischer-Tropsch process to convert syngas into hydrocarbons, and an upgrading and separation process [6]. Generally, these processes require high temperature up to 800 ◦C and high-pressure conditions. Therefore, chemical gas-to-liquid conversion requires high operating costs. Biological gas-to-liquid conversion technology is being developed to address these issues [5]. Biological gas-to-liquid conversion technology uses methanotrophs, which can use methane as a sole carbon source. This gas-to-liquid bioconversion using methanotrophs shows higher efficiency than the chemical conversion [7]. In addition, bioprocess proceeds under normal temperature and pressure conditions. By applying metabolic engineering and systems biology approaches, currently, engineered methanotrophs have been deployed for the production of several products, including secondary metabolites [8–10]. However, there are still some technical issues in the Catalysts 2019, 9, 883; doi:10.3390/catal9110883 www.mdpi.com/journal/catalysts Catalysts 2019, 9, 883 2 of 14 gas-to-liquid bioconversion using methanotrophs, such as limited mass transfer rates of methane, low volumetric productivity, and instability of recombinant strains [11]. Secondary metabolites produced by plants and microorganisms have many useful biological activities. Among the many secondary metabolites, isoprenoids are the largest family of natural products, with more than 50,000 members identified [12–14]. Many isoprenoids have been used in many applications such as pharmaceuticals, nutraceuticals, fragrances, as well as the chemical industry. Additionally, due to the methyl-branched and cyclized hydrocarbon alkene structure, some isoprenoids have attracted more attention for their potential use as advanced biofuels. Plants are the major sources of isoprenoids. However, there are still many limitations for the production of high quantities of natural isoprenoids, including slow growth and tissue-specific biosynthesis, and difficulties in harvesting and extraction [12–14]. In contrast, a promising alternative method for isoprenoid production is the reconstruction of isoprenoid biosynthesis pathways from plants into microbes. The application of this approach has been extensively studied on model organisms like Escherichia coli or Saccharomyces cerevisiae for a variety of isoprenoids [12,14]. E. coli and S. cerevisiae are promising hosts since they possess simple genetic backgrounds, high growth rates as well as well-developed genetic tools. For example, high production of isoprenoid-based biofuels has been achieved in the metabolic engineering of microbes via endogenous or heterologous biosynthetic pathways in these hosts. However, the vast majority of these microbe-based isoprenoid production cases rely on sugar-based metabolism, which is likely to increase in the price of isoprenoids produced in large quantity. The use of alternative carbon sources is attractive in industrial biotechnology for isoprenoid production. Furthermore, different type of pathway regulation in different microbes utilizing unusual carbon substrate like methane can play a vital role in metabolic engineering of various microbes including model organisms. Thus, metabolic engineering of methane-utilizing methanotrophs has recently attracted much attention, due to not only cheaper price of methane but also the novelty and potential of secondary metabolites biosynthetic capability of methanotrophs. Some secondary metabolites were naturally produced in methanotrophs, such as carotenoids and ectoine, which are responsible for the pigmentation and osmotic stress in a high salt environment, respectively [8,10]. Recently, some rational metabolic engineering strategies have been used in methanotrophs as a microbial cell factory platform for the bioconversion of methane to a variety of value-added products [9]. Based on these backgrounds, in this study, the biosynthesis pathways and characteristics of isoprenoids and other secondary metabolites in methanotrophs are reviewed. The current state of the production of various isoprenoids, riboflavin, and ectoine using methanotrophs is overviewed. In later sections of this review, we discuss the potential of methanotrophs and strategies for improving the production of isoprenoids through metabolic engineering of methanotrophs. 2. Methane Metabolism in Methanotrophs Methanotrophs play important roles in global methane cycling and in the degradation of harmful substances. They use methane as a sole carbon source and were isolated in several conditions where methane and oxygen are both present. Freshwater and sediments are sinks of atmospheric methane. A variety of different methanotrophs inhabit these environments, and Methylomonas, Methylobacter, Methylosarcina, Methylococcus, and Methylosoma are predominant. Landfills and rice field soils are major sources of atmospheric methane. Studies have reported that landfills and rice field soils contain a variety of methanotrophs, such as Methylomonas, Methylobacter, Methylosarcina, Methylomicrobium, Methylococcus, Methylocaldum, Methylocystis, and Methylosinus. The distribution and abundance of methanotrophs in these methane-generating environments are affected by oxygen availability. Methanotrophs are also found in various extreme environments such as hot springs, the Antarctic, peatbogs, and deep-sea environments [15]. Methanotrophs are bacteria that have the ability to assimilate methane. This has always been considered a very unique microbial function. Over the past decade, knowledge of methane metabolism has been broadened by the help of systems biology approaches [16]. However, it also highlighted a Catalysts 2019, 9, 883 3 of 14 large amount of fundamental knowledge gaps of methanotrophs that must be addressed to exploit the full potential of methanotrophs [17]. Oxidation of methane is carried out by methane monooxygenase (MMO), a membrane-associated particulate methane monooxygenase (pMMO) and soluble methane monooxygenase (sMMO) [18–20]. After that, methanol dehydrogenase (MDH) oxidized methanol into formaldehyde, which is then assimilated through C1 metabolism [18–20]. While calcium-dependent MDH encoded by mxaFI has been well-investigated, a novel MDH (i.e., lanthanide-dependent MDH encoded by xoxF) has also been discovered [21]. The role of xoxF in methane and methanol oxidation and the divergence and wide distribution of these enzymes among bacterial taxa demonstrated the importance of xoxF enzymes environmentally, and furthermore, xoxF may be ancestral to mxaF. There are two types of methanotrophs—γ-proteobacteria (Type I) and α-proteobacteria (Type II). The distinction between these groups is based on the process of assimilating formaldehyde, the organization and arrangement of cell membranes, and related characteristics such as cell morphology [22,23]. Typically, type I methanotrophs assimilate formaldehyde through the RuMP pathway (including Type X Methylocaldum and Methylococcus). They also form a flat, disc-shaped inner cytoplasm

Load more